Viatris IncVTRS

時価総額

$122.8億

PER

処方薬とジェネリックを扱う医薬品の最大手。循環器から腫瘍まで複雑薬を含むポートフォリオを展開。2024年に第III相資産を350百万ドルで取得、FDAのインド工場警告が影響。米国・欧州・新興市場で展開。

	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net (loss) earnings	-670	-1,269	2,079	55	-634
Depreciation and amortization	2,216	4,507	3,028	2,741	2,893
Deferred income tax benefit	-213	676	-26	-387	-768
Litigation settlements and other contingencies, net	-101	-324	2	-87	-274
Loss (gain) on disposal of business	-	-	1,754	-240	-399
Share-based compensation expense	79	111	116	181	146
Acquired IPR&D	-	-	-	-	-12
Other non-cash items	-366	-412	-434	-595	-298
Accounts receivable	-79	-59	240	-79	-300
Inventories	742	428	260	613	723
Trade accounts payable	-83	-70	170	315	36
Income taxes	4	-700	25	-77	219
Other operating assets and liabilities, net	-46	667	618	415	151
Net cash provided by operating activities	1,232	3,017	2,953	2,800	2,303
Cash paid for acquisitions, net of cash acquired	-416	-277	-	668	350
Capital expenditures	243	457	406	377	326
Payments for product rights and other, net	438	52	37	98	21
Proceeds from sale of property, plant and equipment	2	18	14	14	3
Purchases of IPR&D	-	-	-	-	-12
Proceeds from Divestiture of Businesses	20	97	1,950	364	2,507
Purchase of marketable securities	105	30	30	26	26
Proceeds from the sale of marketable securities	47	30	30	26	26
Net cash provided by (used in) investing activities	-301	-118	1,521	-764	1,801
Proceeds from issuance of long-term debt	983	1,710	1,876	0	-
Payments of long-term debt	2,484	4,201	3,663	1,250	3,714
Payments of financing fees	2	7	2	1	5
Change in short-term borrowings, net	1,100	392	-1,493	0	-
Purchase of ordinary shares	-	-	-	250	250
Taxes paid related to net share settlement of equity awards	8	17	17	38	53
Contingent consideration payments	49	29	19	8	32
Cash dividends paid	-	399	582	576	575
Non-contingent payments for product rights	143	456	-	10	-
Issuance of common stock	-	-	3	3	3
Other items, net	-3	-5	19	-173	295
Net cash used in financing activities	-606	-3,012	-3,878	-2,302	-4,330
Effect on cash of changes in exchange rates	-	-	-39	-2	-31
Net (decrease) increase in cash, cash equivalents and restricted cash	359	-144	556	-269	-257
Income taxes	324	642	735	571	514
Interest	555	685	643	612	561